亚太地区血糖监测市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

亚太血糖监测市场按自我监测血糖设备(血糖仪设备、试纸和柳叶刀)、连续血糖监测设备(传感器和耐用品)和地理划分。

市场快照

Asia-Pacific Blood Glucose Monitoring Market Size
Study Period: 2016-2027
Base Year: 2021
CAGR: >9 %
Asia-Pacific Blood Glucose Monitoring Market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

预计亚太地区血糖监测市场在 2021 年至 2026 年的预测期内复合年增长率将超过 9%,预计到 2026 年市场规模将超过 46 亿美元。亚太地区拥有糖尿病人口最多的国家如中国和印度,平均患病率超过8.5%。血糖监测设备用于有效的糖尿病诊断和治疗。糖尿病人口的增加通过增加血糖监测设备的使用来推动市场。肥胖也被认为是导致疾病状况的主要因素之一,主要是2型糖尿病。此外,技术创新和进步等其他因素为测量血糖水平提供了便利。

报告范围

本研究包括两种主要类型的血糖监测设备。这些设备进一步分为自我监测血糖 (SMBG) 设备(分为血糖仪设备、试纸和柳叶刀)和连续血糖监测 (CGM) 设备,分为传感器和耐用品。该报告对亚太地区血糖监测设备的使用和需求进行了详细分析。

Self-monitoring Blood Glucose Devices
By Component (Value, and Volume, 2016 - 2026)
Glucometer Devices
Test Strips
Lancets
Continuous Glucose Monitoring Devices
By Component (Value, and Volume, 2016 - 2026)
Sensors
Durables
Geography
Asia-Pacific
Japan (Value, and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, Lancets)
Continuous Glucose Monitoring Devices
By Component (Sensors and Durables)
South Korea (Value, and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, Lancets)
Continuous Glucose Monitoring Devices
By Component (Sensors and Durables)
China (Value, and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, Lancets)
Continuous Glucose Monitoring Devices
By Component (Sensors and Durables)
India (Value, and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, Lancets)
Continuous Glucose Monitoring Devices
By Component (Sensors and Durables)
Australia (Value, and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, Lancets)
Continuous Glucose Monitoring Devices
By Component (Sensors and Durables)
Vietnam (Value, and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, Lancets)
Continuous Glucose Monitoring Devices
By Component (Sensors and Durables)
Malaysia (Value, and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, Lancets)
Continuous Glucose Monitoring Devices
By Component (Sensors and Durables)
Indonesia (Value, and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, Lancets)
Continuous Glucose Monitoring Devices
By Component (Sensors and Durables)
Philippines (Value, and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, Lancets)
Continuous Glucose Monitoring Devices
By Component (Sensors and Durables)
Thailand (Value, and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, Lancets)
Continuous Glucose Monitoring Devices
By Component (Sensors and Durables)
Rest of Asia-Pacific (Value, and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, Lancets)
Continuous Glucose Monitoring Devices
By Component (Sensors and Durables)

Report scope can be customized per your requirements. Click here.

主要市场趋势

2020年自我监测血糖仪占主要市场份额

尽管 CGM 是糖尿病患者实时检查血糖读数的先进方法,但与 CGM 相比,SMBG 是亚太地区患者最喜欢的设备,因为其经济实惠且使用复杂程度较低。SMBG细分市场占据亚太地区血糖监测市场75%以上的市场份额。从组件来看,一次性耗材(试纸和柳叶刀)与血糖仪设备相比占据了最大的市场份额。中国和印度在全球糖尿病人口中排名靠前,预计在预测期内这两个国家的糖尿病市场将高速增长。虽然 CGM 为患者提供了实时的血糖水平数据,但其在亚太市场的适应性非常低。

Asia-Pacific Blood Glucose Monitoring Market Trends

2020年中国占亚太市场主要份额

中国正面临世界上最大的糖尿病流行病,约 10% 的人口患有代谢疾病,而近 37% 的人口处于糖尿病前期。2020年,中国在亚太地区 血糖监测市场占有最大份额,这得益于庞大的患者群体和对先进技术的广泛接受。目前中国有超过1200万人患有1型糖尿病,1.14亿人患有2型糖尿病。1型糖尿病的特点是需要胰岛素,而2型糖尿病的特点是胰岛素依赖型糖尿病,1型糖尿病患者需要经常检查自己的血糖水平,这正在推动中国血糖设备市场的发展。

Asia-Pacific Blood Glucose Monitoring Market Growth

竞争格局

亚太血糖监测市场分散,少数主要制造商在亚太市场的主要国家/地区开展业务,而其余制造商则仅限于其他本地或区域特定市场。近期参与者之间的并购帮助企业加强了市场占有率。例如,2019 年 1 月,Eris Lifesciences 和美敦力就在印度开展糖尿病监测计划展开合作。美敦力宣布计划为印度患者推出其最新的 FDA 批准的 Guardian Connect 设备。Eris 可能会在其患者护理倡议下在诊所和医疗保健提供单位提供该设备。

RECENT DEVELOPMENTS

In May 2021, Taiwan-based company Rossmax’s introduced the Rossmax Health station. The Health Station combines all in one. Blood Glucose Monitoring Devices, Blood Pressure Monitoring, SpO2 & Artery Monitoring, Weight & Body Fat Management as well as Temperature Measurement. The health station can be placed in pharmacies and other public places.

In Mar 2021, Japan-based company Terumo Corporation, patterned with Glooko to deliver Integrated Diabetes Data Solutions to diabetes patients.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

    3. 4.3 Market Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Self-monitoring Blood Glucose Devices

      1. 5.1.1 By Component (Value, and Volume, 2016 - 2026)

        1. 5.1.1.1 Glucometer Devices

        2. 5.1.1.2 Test Strips

        3. 5.1.1.3 Lancets

    2. 5.2 Continuous Glucose Monitoring Devices

      1. 5.2.1 By Component (Value, and Volume, 2016 - 2026)

        1. 5.2.1.1 Sensors

        2. 5.2.1.2 Durables

    3. 5.3 Geography

      1. 5.3.1 Asia-Pacific

        1. 5.3.1.1 Japan (Value, and Volume, 2016 - 2026)

          1. 5.3.1.1.1 Self-monitoring Blood Glucose Devices

            1. 5.3.1.1.1.1 By Component (Glucometer Device, Test strips, Lancets)

          2. 5.3.1.1.2 Continuous Glucose Monitoring Devices

            1. 5.3.1.1.2.1 By Component (Sensors and Durables)

        2. 5.3.1.2 South Korea (Value, and Volume, 2016 - 2026)

          1. 5.3.1.2.1 Self-monitoring Blood Glucose Devices

            1. 5.3.1.2.1.1 By Component (Glucometer Device, Test strips, Lancets)

          2. 5.3.1.2.2 Continuous Glucose Monitoring Devices

            1. 5.3.1.2.2.1 By Component (Sensors and Durables)

        3. 5.3.1.3 China (Value, and Volume, 2016 - 2026)

          1. 5.3.1.3.1 Self-monitoring Blood Glucose Devices

            1. 5.3.1.3.1.1 By Component (Glucometer Device, Test strips, Lancets)

          2. 5.3.1.3.2 Continuous Glucose Monitoring Devices

            1. 5.3.1.3.2.1 By Component (Sensors and Durables)

        4. 5.3.1.4 India (Value, and Volume, 2016 - 2026)

          1. 5.3.1.4.1 Self-monitoring Blood Glucose Devices

            1. 5.3.1.4.1.1 By Component (Glucometer Device, Test strips, Lancets)

          2. 5.3.1.4.2 Continuous Glucose Monitoring Devices

            1. 5.3.1.4.2.1 By Component (Sensors and Durables)

        5. 5.3.1.5 Australia (Value, and Volume, 2016 - 2026)

          1. 5.3.1.5.1 Self-monitoring Blood Glucose Devices

            1. 5.3.1.5.1.1 By Component (Glucometer Device, Test strips, Lancets)

          2. 5.3.1.5.2 Continuous Glucose Monitoring Devices

            1. 5.3.1.5.2.1 By Component (Sensors and Durables)

        6. 5.3.1.6 Vietnam (Value, and Volume, 2016 - 2026)

          1. 5.3.1.6.1 Self-monitoring Blood Glucose Devices

            1. 5.3.1.6.1.1 By Component (Glucometer Device, Test strips, Lancets)

          2. 5.3.1.6.2 Continuous Glucose Monitoring Devices

            1. 5.3.1.6.2.1 By Component (Sensors and Durables)

        7. 5.3.1.7 Malaysia (Value, and Volume, 2016 - 2026)

          1. 5.3.1.7.1 Self-monitoring Blood Glucose Devices

            1. 5.3.1.7.1.1 By Component (Glucometer Device, Test strips, Lancets)

          2. 5.3.1.7.2 Continuous Glucose Monitoring Devices

            1. 5.3.1.7.2.1 By Component (Sensors and Durables)

        8. 5.3.1.8 Indonesia (Value, and Volume, 2016 - 2026)

          1. 5.3.1.8.1 Self-monitoring Blood Glucose Devices

            1. 5.3.1.8.1.1 By Component (Glucometer Device, Test strips, Lancets)

          2. 5.3.1.8.2 Continuous Glucose Monitoring Devices

            1. 5.3.1.8.2.1 By Component (Sensors and Durables)

        9. 5.3.1.9 Philippines (Value, and Volume, 2016 - 2026)

          1. 5.3.1.9.1 Self-monitoring Blood Glucose Devices

            1. 5.3.1.9.1.1 By Component (Glucometer Device, Test strips, Lancets)

          2. 5.3.1.9.2 Continuous Glucose Monitoring Devices

            1. 5.3.1.9.2.1 By Component (Sensors and Durables)

        10. 5.3.1.10 Thailand (Value, and Volume, 2016 - 2026)

          1. 5.3.1.10.1 Self-monitoring Blood Glucose Devices

            1. 5.3.1.10.1.1 By Component (Glucometer Device, Test strips, Lancets)

          2. 5.3.1.10.2 Continuous Glucose Monitoring Devices

            1. 5.3.1.10.2.1 By Component (Sensors and Durables)

        11. 5.3.1.11 Rest of Asia-Pacific (Value, and Volume, 2016 - 2026)

          1. 5.3.1.11.1 Self-monitoring Blood Glucose Devices

            1. 5.3.1.11.1.1 By Component (Glucometer Device, Test strips, Lancets)

          2. 5.3.1.11.2 Continuous Glucose Monitoring Devices

            1. 5.3.1.11.2.1 By Component (Sensors and Durables)

  6. 6. MARKET INDICATORS

    1. 6.1 Type-1 Diabetes Population (2016 - 2026)

    2. 6.2 Type-2 Diabetes Population (2016 - 2026)

  7. 7. COMPETITIVE LANDSCAPE

    1. 7.1 Company Profiles

      1. 7.1.1 Abbott Diabetes Care

      2. 7.1.2 Roche

      3. 7.1.3 Johnson & Johnson

      4. 7.1.4 Dexcom

      5. 7.1.5 Medtronic

      6. 7.1.6 Arkray

      7. 7.1.7 Ascensia Diabetes Care

      8. 7.1.8 Agamatrix Inc.

      9. 7.1.9 Bionime Corporation

      10. 7.1.10 Acon

      11. 7.1.11 Medisana

      12. 7.1.12 Trivida

      13. 7.1.13 Rossmax

  8. 8. MARKET OPPORTUNITIES AND FUTURE TRENDS

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Asia-Pacific Blood Glucose Monitoring Market market is studied from 2016 - 2027.

The Asia-Pacific Blood Glucose Monitoring Market is growing at a CAGR of >9% over the next 5 years.

The Asia-Pacific Blood Glucose Monitoring Market is valued at 2 Billion USD in 2016.

The Asia-Pacific Blood Glucose Monitoring Market is valued at 4 Billion USD in 2027.

Roche, Medtronics, Dexcom, Abbott Diabetes Care, Johnson & Johnson are the major companies operating in Asia-Pacific Blood Glucose Monitoring Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!